ArticleAnnals of surgical oncology2021
ASO Author Reflections: Objective Response Rate after Short Duration (< 9 Weeks) Is Not Inferior to Moderate (9-27 Weeks) or Long Duration (> 27 Weeks) of Neoadjuvant Endocrine Therapy (NET)-An NCDB Analysis.
Laura Burkbauer et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.